| Financial Year |
March 31 2023 |
| Monetary Funds |
1,707,635,143.10 |
| Held-for-trading Financial Assets |
51,140,597.95 |
| Notes Receivable |
78,284,481.39 |
| Accounts Receivable |
1,120,146,712.43 |
| Advances to Suppliers |
73,187,813.29 |
| Other Receivables |
54,755,452.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,339,658,788.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,072,662,202.38 |
| Total Current Assets |
8,499,872,353.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
328,078,033.95 |
| Investment Properties |
365,668,608.90 |
| Fixed Assetes |
1,038,916,642.61 |
| Under-construction Projects |
54,120,501.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
275,738,936.56 |
| R&D expenses |
547,169.80 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
64,901,008.78 |
| Deferred Income Tax Assets |
19,031,828.69 |
| Other Non-Current Assets |
1,796,067,935.30 |
| Sub-Total of Non-Current Assets |
4,472,405,379.85 |
| Total Assets |
12,972,277,733.76 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
185,549,724.00 |
| Accounts Payable |
1,916,841,065.35 |
| Accounts Received In Advance |
17,156,431.88 |
| Employee Compensation Payable |
655,848,402.78 |
| Taxes Payable |
21,756,547.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
343,019,175.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,123,199.03 |
| Other Current Liabilities |
11,301,524.21 |
| Sub-Total of Current Liabilities |
3,971,674,667.30 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,706,876.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
135,031,659.90 |
| Total Liabilities |
4,106,706,327.20 |
| Paid-In Capital(Or Share Stock) |
1,213,650,273.00 |
| Capital Surplus |
1,839,669,112.78 |
| Surplus Reserve |
739,076,899.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,027,594,777.07 |
| Minority Stockholder's Interest |
40,604,522.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,824,966,884.40 |
| Owner's Equity（Stockholder's Equity） |
8,865,571,406.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,972,277,733.76 |
